» Articles » PMID: 38253437

Heterogeneous Brain Abnormalities in Schizophrenia Converge on a Common Network Associated With Symptom Remission

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2024 Jan 22
PMID 38253437
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Hypothesis: There is a huge heterogeneity of magnetic resonance imaging findings in schizophrenia studies. Here, we hypothesized that brain regions identified by structural and functional imaging studies of schizophrenia could be reconciled in a common network.

Study Design: We systematically reviewed the case-control studies that estimated the brain morphology or resting-state local function for schizophrenia patients in the literature. Using the healthy human connectome (n = 652) and a validated technique "coordinate network mapping" to identify a common brain network affected in schizophrenia. Then, the specificity of this schizophrenia network was examined by independent data collected from 13 meta-analyses. The clinical relevance of this schizophrenia network was tested on independent data of medication, neuromodulation, and brain lesions.

Study Results: We identified 83 morphological and 60 functional studies comprising 7389 patients with schizophrenia and 7408 control subjects. The "coordinate network mapping" showed that the atrophy and dysfunction coordinates were functionally connected to a common network although they were spatially distant from each other. Taking all 143 studies together, we identified the schizophrenia network with hub regions in the bilateral anterior cingulate cortex, insula, temporal lobe, and subcortical structures. Based on independent data from 13 meta-analyses, we showed that these hub regions were specifically connected with regions of cortical thickness changes in schizophrenia. More importantly, this schizophrenia network was remarkably aligned with regions involving psychotic symptom remission.

Conclusions: Neuroimaging abnormalities in cross-sectional schizophrenia studies converged into a common brain network that provided testable targets for developing precise therapies.

Citing Articles

Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations in Schizophrenia: A Randomized Clinical Trial.

Hua Q, Wang L, He K, Sun J, Xu W, Zhang L JAMA Netw Open. 2024; 7(11):e2444215.

PMID: 39527055 PMC: 11555553. DOI: 10.1001/jamanetworkopen.2024.44215.


Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the Gene and Dermatoglyphics.

Guardiola-Ripoll M, Sotero-Moreno A, Chaumette B, Kebir O, Hostalet N, Almodovar-Paya C Biomedicines. 2024; 12(10).

PMID: 39457583 PMC: 11505170. DOI: 10.3390/biomedicines12102270.


Investigating the effect of rTMS over the temporoparietal cortex on the Right Ear Advantage for perceived and imagined voices.

Prete G, Rollo B, Palumbo R, Ceccato I, Mammarella N, Di Domenico A Sci Rep. 2024; 14(1):24930.

PMID: 39438571 PMC: 11496506. DOI: 10.1038/s41598-024-75671-z.

References
1.
Darby R, Laganiere S, Pascual-Leone A, Prasad S, Fox M . Finding the imposter: brain connectivity of lesions causing delusional misidentifications. Brain. 2017; 140(2):497-507. PMC: 5278302. DOI: 10.1093/brain/aww288. View

2.
Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q . Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull. 2009; 37(1):199-211. PMC: 3004197. DOI: 10.1093/schbul/sbp099. View

3.
Eickhoff S, Bzdok D, Laird A, Kurth F, Fox P . Activation likelihood estimation meta-analysis revisited. Neuroimage. 2011; 59(3):2349-61. PMC: 3254820. DOI: 10.1016/j.neuroimage.2011.09.017. View

4.
van Erp T, Hibar D, Rasmussen J, Glahn D, Pearlson G, Andreassen O . Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2015; 21(4):547-53. PMC: 4668237. DOI: 10.1038/mp.2015.63. View

5.
Krause-Sorio B, Siddarth P, Kilpatrick L, Laird K, Milillo M, Ercoli L . Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression. J Affect Disord. 2020; 274:464-470. PMC: 7368564. DOI: 10.1016/j.jad.2020.05.092. View